United States Files Lawsuit against PharMerica Corporation for Violations of the False Claims Act and the Controlled Sub

WI 2026 Healthcare / General
OIG False Claims Controlled Substance
Penalty
$0

Outcome

OIG enforcement action against United States Files Lawsuit against PharMerica Corporation for Violations of the False Claims Act and the Controlled Sub for false claims, controlled substance.

Details

United States Files Lawsuit against PharMerica Corporation for Violations of the False Claims Act and the Controlled Sub — OIG Enforcement (2026)

OIG took enforcement action against United States Files Lawsuit against PharMerica Corporation for Violations of the False Claims Act and the Controlled Sub in WI in 2026 involving false claims, controlled substance violations in the Healthcare / General sector.

Violation types: False Claims, Controlled Substance
Entity type: Healthcare Provider
Penalty type: Settlement
Location: WI

Source: United States Files Lawsuit against PharMerica Corporation for Violations of the False Claims Act and the Controlled Substances Act

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's controlled substance tracking enforces DEA-compliant inventory reconciliation, flags prescribing pattern anomalies, and requires segregation of duties for dispensing and record-keeping.

Source: United States Files Lawsuit against PharMerica Corporation for Violations of the False Claims Act and the Controlled Substances Act

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works